Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
new york blog main
5
×
san diego blog main
5
×
deals
san diego top stories
san francisco blog main
boston blog main
merck
national top stories
raleigh-durham blog main
san diego
san francisco top stories
seattle blog main
seattle top stories
startups
antibiotics
arvinas
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer diagnostics
clinical trials
detroit blog main
detroit top stories
drugs
fda
indiana blog main
indiana top stories
ipo
national
new york top stories
raleigh-durham top stories
san francisco
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
company
drug
ipo
make
acquisitions
adding
advance
aims
albert
bacteria
biggest
bio
biology
biopharma
biotechs
bourla
business
ceo
chose
close
crispr
cytokine
deal
decisions
device
diagnostic
diagnostics
disease
drugs
enhanced
exited
expand
fighting
files
firms
fold
future
help
imports
infections
Language
unknown
unset
Current search:
company���s
×
biotech
×
" new york blog main "
×
" san diego blog main "
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way